Skip to Content

Notice

Federal Advisory Committee; Meeting of the Uniform Formulary Beneficiary Advisory Panel

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Assistant Secretary of Defense (Health Affairs), DoD.

ACTION:

Notice of meeting.

SUMMARY:

Under the provisions of the Federal Advisory Committee Act of 1972 (Title 5, United States Code (U.S.C.), Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense announces that the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel) will meet September 23, 2010, in Washington, DC.

DATES:

The meeting will be held on September 23, 2010, from 9 a.m.-12 p.m.

A closed Administrative Work Meeting will be held from 8 a.m. to 9 a.m.

ADDRESSES:

The meetings will be held at the Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Lieutenant Colonel Stacia Spridgen, Designated Federal Officer, Uniform Formulary Beneficiary Advisory Panel; 2450 Stanley Road, Suite 208; Ft. Sam Houston, TX 78234-6102; Telephone: (210) 295-1271, Fax: (210) 295-2789, E-mail: Baprequests@tma.osd.mil.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

Purpose of Meeting

The Panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary.

Meeting Agenda

Sign-In; Welcome and Opening Remarks; Public Citizen Comments; Scheduled Therapeutic Class Reviews—Ophthalmic Agents (Nonsteroidal Anti-Inflammatory, Mast Cell Stabilizers, Steroids, and Antihistamines), Renin-Angiotensin Antihypertensives (RAAS), pertinent utilization management issues, drugs recommended for non-formulary placement due to non-compliance with the National Defense Authorization Act for Fiscal Year 2008, Section 703; Panel Discussions and Vote; and comments following each therapeutic class review.

Meeting Accessibility

Pursuant to 5 U.S.C. 552b, as amended, and Title 41, Code of Federal Regulations (CFR), Section 102-3.140 through 102-3.165, and the availability of space this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly.

Administrative Work Meeting

Prior to the public meeting the Panel will conduct an Administrative Work Meeting from 8 a.m. to 9 a.m. to discuss administrative matters of the Panel. The Administrative Work Meeting will be held at the Naval Heritage Center, 701 Pennsylvania Avenue, NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the Administrative Work Meeting will be closed to the public.

Written Statements

Pursuant to 41 CFR 102-3.105(j) and 102-3.140, the public or interested organizations may submit written statements to the membership of the Panel at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Panel's Designated Federal Officer (DFO). The DFO's contact information can be obtained from the General Services Administration's Federal Advisory Committee Act Database—https://www.fido.gov/​facadatabase/​public.asp.

Written statements that do not pertain to the scheduled meeting of the Panel may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting, then these statements must be submitted no later than 5 business days prior to the meeting in question. The DFO will review all submitted written statements and provide copies to all the committee members.

Public Comments

In addition to written statements, the Panel will set aside 1 hour for individuals or interested groups to address the Panel. To ensure consideration of their comments, individuals and interested groups should submit written statements as outlined in this notice; but if they still want to address the Panel, then they will be afforded the opportunity to register to address the Panel. The Panel's DFO will have a “Sign-Up Roster” available at the Panel meeting, for registration on a first-come, first-served basis. Those wishing to address the Panel will be given no more than 5 minutes to present their comments, and at the end of the 1 hour time period no further public comments will be accepted. Anyone who signs up to address the Panel, but is unable to do so due to the time limitation, may submit their comments in writing; however, they must understand that their written comments may not be reviewed prior to the Panel's deliberation. Accordingly, Start Printed Page 51985the Panel recommends that individuals and interested groups consider submitting written statements instead of addressing the Panel.

Start Signature

Dated: August 19, 2010.

Mitchell S. Bryman,

Alternate OSD Federal Register Liaison Officer, Department of Defense.

End Signature End Supplemental Information

[FR Doc. 2010-21014 Filed 8-23-10; 8:45 am]

BILLING CODE 5001-06-P